News

What’s Next For HIMS Stock After A Solid Q1?
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low.
Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the ...
Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth
The stock of Hims & Hers Health Inc. (HIMS) fell more than 4% in after-hours trading after the telehealth company issued ...
Wegovy Deal Makes Cofounder Of Hair Loss Pill Seller Hims A Billionaire
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout ...
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
24/7 Wall St.2d
Hims & Hers Shows It's More Than Just GLP-1 Drugs
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...